Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janette Vardy

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Pharmacology, Biochemistry, and Behavior|September 11, 2010
Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodentsJoanna E Fardell, Janette Vardy, Warren Logge, et al.
Critical Reviews in Oncology/Hematology|March 31, 2012
The ticking time-bomb of asbestos: its insidious role in the development of malignant mesotheliomaAnthony Linton, Janette Vardy, Stephen Clarke, et al.
Plos One|September 27, 2014
Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implicationsMaryam Hafsah Selamat, Siew Yim Loh, Lynette Mackenzie, et al.
Journal of the National Cancer Institute|September 11, 2019
Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer PatientsFlorence Joly, Hélène Castel, Laure Tron, et al.
The Lancet. Oncology|March 1, 2011
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancerJeffrey S Wefel, Janette Vardy, Tim Ahles, et al.
Pharmacology, Biochemistry, and Behavior|August 29, 2006
The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in miceGordon Winocur, Janette Vardy, Malcolm A Binns, et al.
Anti-Cancer Drugs|May 2, 2002
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature reviewJanette Vardy, Edmond Wong, Michael Izard, et al.
BMC Cancer|May 1, 2009
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trialsJanette Vardy, Ryan Dadasovich, Philip Beale, et al.
Behavioural Brain Research|November 22, 2011
The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in ratsMelissa J Sharpe, Joanna E Fardell, Janette Vardy, et al.
Psychopharmacology|September 7, 2011
Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activityJoanna E Fardell, Janette Vardy, Jeanette D Shah, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Pharmacology, Biochemistry, and Behavior|September 11, 2010
Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodentsJoanna E Fardell, Janette Vardy, Warren Logge, et al.
Critical Reviews in Oncology/Hematology|March 31, 2012
The ticking time-bomb of asbestos: its insidious role in the development of malignant mesotheliomaAnthony Linton, Janette Vardy, Stephen Clarke, et al.
Plos One|September 27, 2014
Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implicationsMaryam Hafsah Selamat, Siew Yim Loh, Lynette Mackenzie, et al.
Journal of the National Cancer Institute|September 11, 2019
Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer PatientsFlorence Joly, Hélène Castel, Laure Tron, et al.
The Lancet. Oncology|March 1, 2011
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancerJeffrey S Wefel, Janette Vardy, Tim Ahles, et al.
Pharmacology, Biochemistry, and Behavior|August 29, 2006
The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in miceGordon Winocur, Janette Vardy, Malcolm A Binns, et al.
Anti-Cancer Drugs|May 2, 2002
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature reviewJanette Vardy, Edmond Wong, Michael Izard, et al.
BMC Cancer|May 1, 2009
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trialsJanette Vardy, Ryan Dadasovich, Philip Beale, et al.
Behavioural Brain Research|November 22, 2011
The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in ratsMelissa J Sharpe, Joanna E Fardell, Janette Vardy, et al.
Psychopharmacology|September 7, 2011
Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activityJoanna E Fardell, Janette Vardy, Jeanette D Shah, et al.
Pageof 7